EP3890652B1 - A syringe for storing and dispensing a material - Google Patents
A syringe for storing and dispensing a material Download PDFInfo
- Publication number
- EP3890652B1 EP3890652B1 EP19813148.4A EP19813148A EP3890652B1 EP 3890652 B1 EP3890652 B1 EP 3890652B1 EP 19813148 A EP19813148 A EP 19813148A EP 3890652 B1 EP3890652 B1 EP 3890652B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- chamber
- syringe
- wall
- cartridge
- blank
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims description 16
- 230000007704 transition Effects 0.000 description 12
- 239000005548 dental material Substances 0.000 description 7
- 230000003068 static effect Effects 0.000 description 7
- 239000012790 adhesive layer Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000009969 flowable effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010944 pre-mature reactiony Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C9/00—Impression cups, i.e. impression trays; Impression methods
- A61C9/0026—Syringes or guns for injecting impression material; Mixing impression material for immediate use
Definitions
- the invention relates to a syringe for storing and dispensing a first and a second component of a material, and in particular to a syringe that has a first and a second chamber that are separated from each other by an empty blank chamber.
- Dental materials are often provided in the form of two or more components that are stored separate from each other and mixed just before use. Such multi-component dental materials may be provided in a syringe that has two or more chambers for each component. There are a variety of syringes for storing and dispensing dental materials that are provided in the form of two or more components.
- US 4,989,758 relates to a double cartridge for two-component compounds.
- the double cartridge is manufactured in one piece by injection molding and has separate reservoir cylinders.
- the double cartridge enables the storage of the components therein for a long time, without the occurrence of an undesired premature reaction due to diffusion through the plastic material of the cartridge.
- EP 1 602 415 A1 describes a syringe comprising a cartridge, a plug, a piston assembly and a mixing tip for a multi-component paste.
- the cartridge may be formed by two concentric arranged barrels forming the component chambers for storing the paste components.
- the invention relates to a syringe for storing and dispensing a first and a second component of a material, in particular a dental material.
- the syringe comprises a first chamber and a second chamber.
- the first chamber contains or can contain the first component
- the second chamber contains or can contain the second component.
- the syringe further comprises an empty blank chamber that spaces the first and second chamber from each other.
- the material stored in the syringe can be prepared for use by combining, for example by merging or mixing, the first and second component.
- the blank chamber is preferably free from any component that is used or required for preparing the material stored in the syringe. More preferably, the blank chamber is empty. The term "empty" thereby means that preferably nothing than eventually air is present in the blank chamber.
- the invention is advantageous in that it provides a syringe that allows for storing individual material components separated and spaced from each other. Thus, diffusion between the material components can be minimized or prevented. Further, the invention provides for a syringe that has a cartridge exhibiting a smooth outer cartridge surface. The smooth outer cartridge surface enables quick and efficient cleaning through wiping the cartridge off. Further, the smooth outer cartridge surface minimizes or eliminates any areas that are difficult to access during wiping off. The invention is further advantageous in that it provides a cartridge that can be easily manufactured, for example by injection molding. Thus, the invention helps minimizing the costs for manufacturing the cartridge and helps maximizing the hygiene level during use of the syringe.
- the blank chamber and the first and second chamber each extend straight and parallel to a longitudinal axis.
- the first and second chamber have a first and second chamber length, respectively, in a dimension parallel to the longitudinal axis.
- the first and second chamber preferably each extend at a uniform cross-section along the first and second length, respectively.
- the first and second chamber each extend at a circular cross-section. Other shapes are possible, for example an oval or D-shaped cross-section.
- the blank chamber extends at least over the longer of, or both of, the first and second chamber length.
- first and second chamber length may be equal and the blank chamber may have a blank chamber length in a dimension parallel to the longitudinal axis.
- the blank chamber length may be equal to the first and second chamber length.
- the syringe has a cartridge front wall that closes a front end of each of the blank chamber and the first and second chamber.
- the first chamber has a first dispensing outlet.
- the second chamber has a second dispensing outlet.
- the first and second dispensing outlet each extend through the cartridge front wall.
- the front end of the blank chamber and the front ends of the first and second chamber further form a front end of the cartridge.
- the front end of the cartridge comprises the first and second dispensing outlet.
- the first and second dispensing outlet may be part of a receptacle of the cartridge, for receiving a mixer, preferably a static mixer, thereon.
- the syringe may comprise a mixer, preferably a static mixer.
- the mixer preferably has an inlet for connecting to the first and second dispensing outlet of the cartridge.
- the syringe is configured for advancing the first and second component through the mixer where the first and second component are mixed as they flow through the mixer.
- the blank chamber does not comprise a dispensing outlet.
- the blank chamber is prevented from picking up any undesired substances that may be present at the front end of the cartridge, for example during use of the syringe in a patient's mouth.
- a first piston is received within the first chamber and closes a rear end of the first chamber.
- a second piston is preferably received within the second chamber and closes a rear end of the second chamber.
- the rear end of the first and second chamber are located at or adjacent a rear end of the cartridge.
- the rear end of the cartridge is located opposite of the front end of the cartridge.
- the rear end of the cartridge may have a fingerplate for supporting the cartridge for advancing or expelling the first and second component.
- the syringe has a first plunger arranged adjacent the rear end of the first chamber and a second plunger arranged adjacent the rear end of the second chamber.
- the first plunger is preferably connected to (or is monolithically formed with) the first piston and the second plunger is connected to (or is monolithically formed with) the second piston.
- the first and second plunger may be connected to each other.
- a fingerplate may be arranged at a rear end of each of the first and second plunger. The fingerplate preferably connects the first and second plunger with each other.
- the rear end of the blank chamber is open.
- the blank chamber may form a reservoir.
- the reservoir may be used for accommodating an applicator therein.
- an applicator may be selected from a brush or a spatula for example.
- the first chamber is formed by a circumferential first chamber wall and the second chamber is formed by a circumferential second chamber wall.
- the first and second chamber wall forms an inner surface which may be cylindrical or of an oval or D-shaped cross-section as mentioned above.
- the syringe may further comprise a first connecting wall connecting the first and second chamber wall.
- the syringe may further comprise a second connecting wall connecting the first and second chamber wall.
- the first and second chamber wall may be indirectly connected to each other by both, the first and second connecting wall.
- the first and second chamber wall may not be in direct contact with each other.
- the first and second chamber wall do not form any common wall with each other.
- the blank chamber is formed between the first chamber wall, the second chamber wall, the first connecting wall and the second connecting wall.
- a portion of the first chamber wall, a portion of the second chamber wall, the first connecting wall and the second connecting wall preferably delimit the blank chamber.
- the first and second connecting wall extend tangentially from the first chamber wall.
- the first and second connecting wall extend tangentially from the second chamber wall.
- tangentially means that the first and second connecting wall at a joint to the first chamber wall (or second chamber wall) each extend along a path on a tangent of the first chamber wall (or the second chamber wall).
- first chamber wall, the second chamber wall, the first connecting wall and the second connecting wall transition into each other smoothly, in particular without a groove formed between the first and second chamber wall. This facilitates cleaning and disinfection by wiping, because areas at the cartridge that are difficult to access are minimized.
- first and second connecting wall each have an outer planar surface.
- the outer planar surface is preferably a surface that faces in a direction away from the syringe, in particular radially away from the longitudinal axis.
- a cartridge with a planar shape of the first and second connecting wall preferably forms an outer cartridge surface that extends at a racetrack-shaped cross-section.
- first and second connecting wall each have an outer surface that corresponds to a cylinder segment.
- the outer surface corresponding to a cylinder segment preferably faces in a direction away from the syringe, in particular radially away from the longitudinal axis.
- a cylinder segment for the purpose of the present specification extends over less than 360 degrees of a full cylinder.
- a cartridge in which the first and second connecting wall has an outer surface corresponding to a cylinder segment preferably forms an outer cartridge surface that is cylindrical (meaning having a shape of a full cylinder). Therefore, the first and second connecting wall in combination with a portion of the first chamber wall and a portion of the second chamber wall, may form an outer cartridge surface that is cylindrical.
- the syringe has a label.
- the label is preferably adhered on the outer cartridge surface. Therefore, the label preferably has an adhesive layer provided on one major side of the label. Preferably the adhesive layer is provided over the entire major side of the label. Due to the shape of the outer cartridge surface (with only tangential transitions between the first and second chamber wall and the first and second connecting wall) the label may be adhered on the outer cartridge surface with the entire adhesive layer in contact with the cartridge.
- the label is preferably nowhere spaced from the cartridge. Therefore, areas between the cartridge and the label that are difficult to access or in which bacteria or undesired substances can accumulate are minimized. Thus, the syringe helps maximizing the hygiene level during use.
- the cartridge is monolithically formed, for example injection molded.
- the first and second chamber wall as well as the first and second connecting wall are preferably monolithically formed, for example injection molded.
- Fig. 1 shows an exemplary syringe 1 of the invention.
- the syringe 1 has a cartridge 10 in which a material in the form of a first and a second flowable component can be stored separated from each other.
- the syringe 1 is configured for expelling the first and second component. Therefore, the syringe 1 comprises a plunger arrangement 11 that has a first and a second plunger 12, 13.
- the first and second plunger 12, 13 are (partially) received within a first and a second chamber 14, 15, respectively.
- a front end 16 of the first plunger 12 is received within the first chamber 14, and a front end 17 of the second plunger 13 is received within the second chamber 15.
- the plunger arrangement 11 (and thus the first and second plunger 12, 13) are pushed forward in a direction toward a front end 18 of the syringe 1.
- the syringe 1 at a front end 25 of the cartridge 10 has a receptacle 19 to which a static mixer (see 30 in Fig. 2 ) can be attached.
- the first and second component, expelled from the first and second chamber 14, 15, are guided through the static mixer where they are merged and mixed as they flow through the static mixer.
- the first chamber 14 has a first dispensing outlet 14a and the second chamber 15 has a second dispensing outlet 15a.
- the first and second dispensing outlet 14a, 15a extend through a cartridge front wall 28.
- the first and second dispensing outlet 14a, 15a are connectable to an inlet 31 (or inlets) of the static mixer 30.
- the material (not shown) present in the first and second chamber 14, 15 is preferably a hardenable dental material.
- the first and second component (stored in the first and second chamber 14, 15, respectively) are flowable and are composed so as to harden or otherwise increase viscosity (typically by chemical reaction) once they are mixed.
- the front end 16 of the first plunger 12 and the front end 17 of the second plunger 13 form a first and a second seal 16a, 17a, respectively.
- the first and second seal 16a, 17a seal the first and second chamber 14, 15, respectively.
- the first and second seal 16a, 17a seal a rear end 26 of the cartridge 10.
- the first and second seal 16a, 17a each form a conical lip seal.
- Such a conical lip seal typically provides for an increased sealing effect in response to an increased pressure during advancing the material or component.
- Fig. 3 shows a cross-section of the cartridge 10.
- the cartridge 10 forms the first and the second chamber 14, 15 (see also Figures 2 and 3 ).
- the first chamber 14 is formed by a circumferential first chamber wall 20 and the second chamber 12 is formed by a circumferential second chamber wall 21.
- the first and second chamber 14, 15 are formed by circumferentially closed and side-by-side arranged barrels that are not in direct contact with each other.
- the cartridge 10 further comprises a first connecting wall 22 that connects the first and second chamber wall 20, 21 with each other. Furthermore, the cartridge 10 comprises a second connecting wall 23 connecting the first and second chamber wall 20, 21 with each other. Thus, the barrels (or the first and second chamber wall 20, 21) are only indirectly connected to each other and are otherwise spaced from each other.
- a blank chamber 24 is formed between the first chamber wall 20, the second chamber wall 21, the first connecting wall 22 and the second connecting wall 23.
- the blank chamber 24 spaces the first and second chamber 14, 15 (and the first and second chamber wall 20, 21) from each other.
- the blank chamber 24 further is empty, meaning the blank chamber 24 does not contain any material or component thereof that is to be dispensed from the syringe 1.
- the first and second chamber wall 20, 21 and the first and second connecting wall 22, 23 in combination provide the cartridge 10 with an outer cartridge surface 27.
- the outer cartridge surface 27 is thus composed of:
- the first and the fourth outer surface portion 27a, 27d transition into each other based on the same tangent on the first and fourth outer surface portion 27a, 27d. Further, the fourth and the second outer surface portion 27d, 27b transition into each other based on the same tangent on the fourth and second outer surface portion 27d, 27b. The second and the third outer surface portion 27b, 27c transition into each other based on the same tangent on the second and third outer surface portion 27b, 27c. And the third and the first outer surface portion 27c, 27a transition into each other based on the same tangent on the third and first outer surface portion 27c, 27a. Accordingly, the outer cartridge surface 27 is free of sharp transitions, cavities, grooves or edges. This facilitates the cleaning by wiping off the outer cartridge surface 27 with a disinfectant because bacteria are hindered in hiding or being trapped in areas that cannot be easily accessed. In the example the outer cartridge surface 27 extends straight and at a racetrack-shaped cross-section.
- Fig. 4 shows an alternative cross-section of the cartridge 10.
- the cartridge 10 forms the first and the second chamber 14, 15 (see also Figures 2 , 3 and 4 ).
- the first and second chamber 14, 15 are formed by a circumferential first and second chamber wall 20, 12, respectively.
- the first and second chamber 14, 15 are formed by circumferentially closed and side-by-side arranged barrels that are not in direct contact with each other.
- the cartridge 10 further comprises a first connecting wall 22 that connects the first and second chamber wall 20, 21 with each other. Furthermore, the cartridge 10 comprises a second connecting wall 23 connecting the first and second chamber wall 20, 21 with each other.
- a blank chamber 24 is formed between the first chamber wall 20, the second chamber wall 21, the first connecting wall 22 and the second connecting wall 23.
- the blank chamber 24 spaces the first and second chamber 14, 15 (and the first and second chamber wall 20, 21) from each other.
- the blank chamber 24 further is empty, meaning the blank chamber 24 does not contain any material or component thereof that is to be dispensed from the syringe 1.
- the blank chamber might be used for storing other items, e.g. an instruction of use or mixing equipment (e.g. static mixer).
- the first and second chamber wall 20, 21 and the first and second connecting wall 22, 23 in combination provide the cartridge 10 with an outer cartridge surface 27.
- the outer cartridge surface 27 is thus composed of:
- the first and the fourth outer surface portion 27a, 27d transition into each other based on the same tangent on the first and fourth outer surface portion 27a, 27d. Further, the fourth and the second outer surface portion 27d, 27b transition into each other based on the same tangent on the fourth and second outer surface portion 27d, 27b. The second and the third outer surface portion 27b, 27c transition into each other based on the same tangent on the second and third outer surface portion 27b, 27c. And the third and the first outer surface portion 27c, 27a transition into each other based on the same tangent on the third and first outer surface portion 27c, 27a. Accordingly, the outer cartridge surface 27 is free of sharp transitions, cavities, grooves or edges. In the example the outer cartridge surface 27 is cylindrical.
- the syringe further comprises a plurality of empty blank chambers that provide spaces between portions of the first and second chamber from each other.
- the empty blank chambers comprise a circular triangle cross-sectional shape (see Figure 5 ).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Epidemiology (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
- The invention relates to a syringe for storing and dispensing a first and a second component of a material, and in particular to a syringe that has a first and a second chamber that are separated from each other by an empty blank chamber.
- Dental materials are often provided in the form of two or more components that are stored separate from each other and mixed just before use. Such multi-component dental materials may be provided in a syringe that has two or more chambers for each component. There are a variety of syringes for storing and dispensing dental materials that are provided in the form of two or more components.
- To maximize the shelf-life of syringes that are pre-filled with the dental materials it has been proposed to store the components of the dental materials in separated chambers.
- For example,
US 4,989,758 relates to a double cartridge for two-component compounds. The double cartridge is manufactured in one piece by injection molding and has separate reservoir cylinders. The double cartridge enables the storage of the components therein for a long time, without the occurrence of an undesired premature reaction due to diffusion through the plastic material of the cartridge. -
EP 1 602 415 A1 describes a syringe comprising a cartridge, a plug, a piston assembly and a mixing tip for a multi-component paste. The cartridge may be formed by two concentric arranged barrels forming the component chambers for storing the paste components. - Although existing syringes and cartridges provide advantages regarding shelf-life there is still a need for a syringe providing for a maximized shelf-life of the material stored therein and which further helps maximizing the hygiene level during use. Such a syringe further still shall be manufactured at minimized costs.
- The invention is as defined in the appended claims.
- The invention relates to a syringe for storing and dispensing a first and a second component of a material, in particular a dental material. The syringe comprises a first chamber and a second chamber. The first chamber contains or can contain the first component, and the second chamber contains or can contain the second component. The syringe further comprises an empty blank chamber that spaces the first and second chamber from each other.
- Preferably, the material stored in the syringe can be prepared for use by combining, for example by merging or mixing, the first and second component. The blank chamber is preferably free from any component that is used or required for preparing the material stored in the syringe. More preferably, the blank chamber is empty. The term "empty" thereby means that preferably nothing than eventually air is present in the blank chamber.
- The invention is advantageous in that it provides a syringe that allows for storing individual material components separated and spaced from each other. Thus, diffusion between the material components can be minimized or prevented. Further, the invention provides for a syringe that has a cartridge exhibiting a smooth outer cartridge surface. The smooth outer cartridge surface enables quick and efficient cleaning through wiping the cartridge off. Further, the smooth outer cartridge surface minimizes or eliminates any areas that are difficult to access during wiping off. The invention is further advantageous in that it provides a cartridge that can be easily manufactured, for example by injection molding. Thus, the invention helps minimizing the costs for manufacturing the cartridge and helps maximizing the hygiene level during use of the syringe.
- In one embodiment the blank chamber and the first and second chamber each extend straight and parallel to a longitudinal axis. Preferably the first and second chamber have a first and second chamber length, respectively, in a dimension parallel to the longitudinal axis. The first and second chamber preferably each extend at a uniform cross-section along the first and second length, respectively. Preferably the first and second chamber each extend at a circular cross-section. Other shapes are possible, for example an oval or D-shaped cross-section.
- In an embodiment the blank chamber extends at least over the longer of, or both of, the first and second chamber length. For example, the first and second chamber length may be equal and the blank chamber may have a blank chamber length in a dimension parallel to the longitudinal axis. The blank chamber length may be equal to the first and second chamber length.
- According to the invention, the syringe has a cartridge front wall that closes a front end of each of the blank chamber and the first and second chamber. The first chamber has a first dispensing outlet. The second chamber has a second dispensing outlet. The first and second dispensing outlet each extend through the cartridge front wall. The front end of the blank chamber and the front ends of the first and second chamber further form a front end of the cartridge. Accordingly, the front end of the cartridge comprises the first and second dispensing outlet. The first and second dispensing outlet may be part of a receptacle of the cartridge, for receiving a mixer, preferably a static mixer, thereon. Accordingly, the syringe may comprise a mixer, preferably a static mixer. The mixer preferably has an inlet for connecting to the first and second dispensing outlet of the cartridge. Thus, the syringe is configured for advancing the first and second component through the mixer where the first and second component are mixed as they flow through the mixer.
- According to the invention, the blank chamber does not comprise a dispensing outlet. Thus, the blank chamber is prevented from picking up any undesired substances that may be present at the front end of the cartridge, for example during use of the syringe in a patient's mouth.
- In one embodiment a first piston is received within the first chamber and closes a rear end of the first chamber. A second piston is preferably received within the second chamber and closes a rear end of the second chamber. The rear end of the first and second chamber are located at or adjacent a rear end of the cartridge. The rear end of the cartridge is located opposite of the front end of the cartridge. The rear end of the cartridge may have a fingerplate for supporting the cartridge for advancing or expelling the first and second component.
- In a further embodiment the syringe has a first plunger arranged adjacent the rear end of the first chamber and a second plunger arranged adjacent the rear end of the second chamber. The first plunger is preferably connected to (or is monolithically formed with) the first piston and the second plunger is connected to (or is monolithically formed with) the second piston. The first and second plunger may be connected to each other. For example, a fingerplate may be arranged at a rear end of each of the first and second plunger. The fingerplate preferably connects the first and second plunger with each other.
- In a further embodiment the rear end of the blank chamber is open. Thus, the blank chamber may form a reservoir. The reservoir may be used for accommodating an applicator therein. Such an applicator may be selected from a brush or a spatula for example.
- In one embodiment the first chamber is formed by a circumferential first chamber wall and the second chamber is formed by a circumferential second chamber wall. The first and second chamber wall forms an inner surface which may be cylindrical or of an oval or D-shaped cross-section as mentioned above. The syringe may further comprise a first connecting wall connecting the first and second chamber wall. And the syringe may further comprise a second connecting wall connecting the first and second chamber wall. Thus, the first and second chamber wall may be indirectly connected to each other by both, the first and second connecting wall. Further, the first and second chamber wall may not be in direct contact with each other. In particular, preferably the first and second chamber wall do not form any common wall with each other.
- Preferably the blank chamber is formed between the first chamber wall, the second chamber wall, the first connecting wall and the second connecting wall. In particular, a portion of the first chamber wall, a portion of the second chamber wall, the first connecting wall and the second connecting wall preferably delimit the blank chamber. Preferably the first and second connecting wall (each) extend tangentially from the first chamber wall. Further, preferably the first and second connecting wall (each) extend tangentially from the second chamber wall. The term "tangentially" means that the first and second connecting wall at a joint to the first chamber wall (or second chamber wall) each extend along a path on a tangent of the first chamber wall (or the second chamber wall). Thus, the first chamber wall, the second chamber wall, the first connecting wall and the second connecting wall transition into each other smoothly, in particular without a groove formed between the first and second chamber wall. This facilitates cleaning and disinfection by wiping, because areas at the cartridge that are difficult to access are minimized.
- In one embodiment the first and second connecting wall each have an outer planar surface. The outer planar surface is preferably a surface that faces in a direction away from the syringe, in particular radially away from the longitudinal axis. A cartridge with a planar shape of the first and second connecting wall preferably forms an outer cartridge surface that extends at a racetrack-shaped cross-section.
- In a further embodiment the first and second connecting wall each have an outer surface that corresponds to a cylinder segment. The outer surface corresponding to a cylinder segment preferably faces in a direction away from the syringe, in particular radially away from the longitudinal axis. A cylinder segment for the purpose of the present specification extends over less than 360 degrees of a full cylinder. A cartridge in which the first and second connecting wall has an outer surface corresponding to a cylinder segment preferably forms an outer cartridge surface that is cylindrical (meaning having a shape of a full cylinder). Therefore, the first and second connecting wall in combination with a portion of the first chamber wall and a portion of the second chamber wall, may form an outer cartridge surface that is cylindrical.
- In one embodiment the syringe has a label. The label is preferably adhered on the outer cartridge surface. Therefore, the label preferably has an adhesive layer provided on one major side of the label. Preferably the adhesive layer is provided over the entire major side of the label. Due to the shape of the outer cartridge surface (with only tangential transitions between the first and second chamber wall and the first and second connecting wall) the label may be adhered on the outer cartridge surface with the entire adhesive layer in contact with the cartridge. In particular the label is preferably nowhere spaced from the cartridge. Therefore, areas between the cartridge and the label that are difficult to access or in which bacteria or undesired substances can accumulate are minimized. Thus, the syringe helps maximizing the hygiene level during use.
- In one embodiment the cartridge is monolithically formed, for example injection molded. In particular, the first and second chamber wall as well as the first and second connecting wall are preferably monolithically formed, for example injection molded.
-
- Fig. 1
- is a perspective view of a syringe according to an embodiment of the invention;
- Fig. 2
- is a perspective cross-sectional view of the syringe shown in
Fig. 1 ; - Fig. 3
- is a cross-sectional view of a cartridge of a syringe according to an embodiment of the invention; and
- Fig. 4
- is a cross-sectional view of a further cartridge of a syringe according to an embodiment of the invention;
- Fig. 5
- is a cross-sectional view of a further cartridge of a syringe according to a further embodiment of the invention.
-
Fig. 1 shows an exemplary syringe 1 of the invention. The syringe 1 has acartridge 10 in which a material in the form of a first and a second flowable component can be stored separated from each other. The syringe 1 is configured for expelling the first and second component. Therefore, the syringe 1 comprises a plunger arrangement 11 that has a first and asecond plunger second plunger second chamber front end 16 of thefirst plunger 12 is received within thefirst chamber 14, and afront end 17 of thesecond plunger 13 is received within thesecond chamber 15. Thefront end 16 of thefirst plunger 12 and thefront end 17 of thesecond plunger 13 in combination form a front end (16, 17) of the plunger arrangement 11. For expelling the first and second component, the plunger arrangement 11 (and thus the first andsecond plunger 12, 13) are pushed forward in a direction toward afront end 18 of the syringe 1. In the example the syringe 1 at afront end 25 of thecartridge 10 has areceptacle 19 to which a static mixer (see 30 inFig. 2 ) can be attached. The first and second component, expelled from the first andsecond chamber - As shown in
Fig. 2 thefirst chamber 14 has afirst dispensing outlet 14a and thesecond chamber 15 has asecond dispensing outlet 15a. The first andsecond dispensing outlet cartridge front wall 28. The first andsecond dispensing outlet static mixer 30. - The material (not shown) present in the first and
second chamber second chamber - The
front end 16 of thefirst plunger 12 and thefront end 17 of thesecond plunger 13 form a first and asecond seal second seal second chamber cartridge 10 is filled with the first and second component the first andsecond seal rear end 26 of thecartridge 10. In the embodiment, the first andsecond seal -
Fig. 3 shows a cross-section of thecartridge 10. Thecartridge 10 forms the first and thesecond chamber 14, 15 (see alsoFigures 2 and3 ). Thefirst chamber 14 is formed by a circumferentialfirst chamber wall 20 and thesecond chamber 12 is formed by a circumferentialsecond chamber wall 21. In other words, the first andsecond chamber - The
cartridge 10 further comprises a first connectingwall 22 that connects the first andsecond chamber wall cartridge 10 comprises a second connectingwall 23 connecting the first andsecond chamber wall second chamber wall 20, 21) are only indirectly connected to each other and are otherwise spaced from each other. - A
blank chamber 24 is formed between thefirst chamber wall 20, thesecond chamber wall 21, the first connectingwall 22 and the second connectingwall 23. Theblank chamber 24 spaces the first andsecond chamber 14, 15 (and the first andsecond chamber wall 20, 21) from each other. Theblank chamber 24 further is empty, meaning theblank chamber 24 does not contain any material or component thereof that is to be dispensed from the syringe 1. - The first and
second chamber wall wall cartridge 10 with anouter cartridge surface 27. Theouter cartridge surface 27 is thus composed of: - a first outer
cartridge surface portion 27a (provided by the first chamber wall 20), - a second outer
cartridge surface portion 27b (provided by the second chamber wall 21), - a third outer
cartridge surface portion 27c (provided by the first connecting wall 22) and - a fourth outer
cartridge surface portion 27d (provided by the second connecting wall 23). - The first and the fourth
outer surface portion outer surface portion outer surface portion outer surface portion outer surface portion outer surface portion outer surface portion outer surface portion outer cartridge surface 27 is free of sharp transitions, cavities, grooves or edges. This facilitates the cleaning by wiping off theouter cartridge surface 27 with a disinfectant because bacteria are hindered in hiding or being trapped in areas that cannot be easily accessed. In the example theouter cartridge surface 27 extends straight and at a racetrack-shaped cross-section. -
Fig. 4 shows an alternative cross-section of thecartridge 10. Again, thecartridge 10 forms the first and thesecond chamber 14, 15 (see alsoFigures 2 ,3 and 4 ). The first andsecond chamber second chamber wall second chamber - The
cartridge 10 further comprises a first connectingwall 22 that connects the first andsecond chamber wall cartridge 10 comprises a second connectingwall 23 connecting the first andsecond chamber wall - A
blank chamber 24 is formed between thefirst chamber wall 20, thesecond chamber wall 21, the first connectingwall 22 and the second connectingwall 23. Theblank chamber 24 spaces the first andsecond chamber 14, 15 (and the first andsecond chamber wall 20, 21) from each other. Theblank chamber 24 further is empty, meaning theblank chamber 24 does not contain any material or component thereof that is to be dispensed from the syringe 1. However, if desired the blank chamber might be used for storing other items, e.g. an instruction of use or mixing equipment (e.g. static mixer). - The first and
second chamber wall wall cartridge 10 with anouter cartridge surface 27. Theouter cartridge surface 27 is thus composed of: - a first outer
cartridge surface portion 27a (provided by the first chamber wall 20), - a second outer
cartridge surface portion 27b (provided by the second chamber wall 21), - a third outer
cartridge surface portion 27c (provided by the first connecting wall 22) and - a fourth outer
cartridge surface portion 27d (provided by the second connecting wall 23). - The first and the fourth
outer surface portion outer surface portion outer surface portion outer surface portion outer surface portion outer surface portion outer surface portion outer surface portion outer cartridge surface 27 is free of sharp transitions, cavities, grooves or edges. In the example theouter cartridge surface 27 is cylindrical. - Alternative embodiments of these devices could be made with the two inner barrels in direct but tangential contact with each other. The separating wall between them would be the additive thickness of each barrel wall. This would form a syringe with 4 parallel chambers: two side-by-side cylindrical chambers containing paste or other flowable material, which separate two empty chambers whose cross sections are circular horn triangles.
- In another embodiment the syringe further comprises a plurality of empty blank chambers that provide spaces between portions of the first and second chamber from each other. In yet another embodiment the empty blank chambers comprise a circular triangle cross-sectional shape (see
Figure 5 ).
Claims (13)
- A syringe (1) for storing and dispensing a first and a second component of a material,
comprising a first chamber (14) containing the first component and a second chamber (15) containing the second component, wherein the syringe further comprises an empty blank chamber (24) that spaces the first (14) and second chamber (15) from each other; wherein the syringe further comprises a cartridge front wall (28) that closes a front end of each of the blank chamber and the first and second chamber, wherein the first chamber (14) has a first dispensing outlet (14a) and the second chamber has a second dispensing outlet (15a), wherein the first and second dispensing outlet each extend through the cartridge front wall, and wherein the blank chamber does not comprise a dispensing outlet. - The syringe of claim 1, wherein the blank chamber and the first and second chamber each extend straight and parallel to a longitudinal axis.
- The syringe of claim 2, wherein the first and second chamber have a first and second chamber length, respectively, in a dimension parallel to the longitudinal axis, and wherein the first and second chamber each extend at a uniform cross-section along the first and second length, respectively.
- The syringe of claim 3, wherein the blank chamber extends at least over the longer of or both of the first and second chamber length.
- The syringe of claim 1, wherein a first piston is received within the first chamber and closes a rear end of the first chamber, and wherein a second piston is received within the second chamber and closes a rear end of the second chamber.
- The syringe of claim 5, having a first plunger arranged adjacent the rear end of the first chamber and a second plunger arranged adjacent the rear end of the second chamber, wherein the first plunger is connected to the first piston and the second plunger is connected to the second piston.
- The syringe of claim 5, wherein the rear end of the blank chamber is open.
- The syringe of claim 1, wherein the first chamber is formed by a circumferential first chamber wall and the second chamber is formed by a circumferential second chamber wall, and wherein the syringe further comprises a first connecting wall connecting the first and second chamber wall and a second connecting wall also connecting the first and second chamber wall, wherein the blank chamber is formed between the first chamber wall, the second chamber wall, the first connecting wall and the second connecting wall.
- The syringe of claim 8, wherein the first and second connecting wall extend tangentially from the first chamber wall and tangentially from the second chamber wall.
- The syringe of claim 9, wherein the first and second connecting wall each have an outer planar surface.
- The syringe of claim 9, wherein the first and second connecting wall each have an outer surface that corresponds to a cylinder segment.
- The syringe of claim 11, wherein the first and second connecting wall in combination with a portion of the first chamber wall and a portion of the second chamber wall, forms a cylindrical outer cartridge surface.
- The syringe of claim 1, comprising two empty blank chambers.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18209967 | 2018-12-04 | ||
PCT/IB2019/060072 WO2020115600A1 (en) | 2018-12-04 | 2019-11-22 | A syringe for storing and dispensing a material |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3890652A1 EP3890652A1 (en) | 2021-10-13 |
EP3890652B1 true EP3890652B1 (en) | 2022-12-28 |
Family
ID=64604480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19813148.4A Active EP3890652B1 (en) | 2018-12-04 | 2019-11-22 | A syringe for storing and dispensing a material |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220023538A1 (en) |
EP (1) | EP3890652B1 (en) |
JP (1) | JP2022510668A (en) |
CN (1) | CN113164236A (en) |
WO (1) | WO2020115600A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3771452A1 (en) | 2019-08-02 | 2021-02-03 | 3M Innovative Properties Company | A syringe assembly |
WO2024057144A1 (en) | 2022-09-16 | 2024-03-21 | Solventum Intellectual Properties Company | Dental product with reduced extrusion forces |
WO2024261563A1 (en) | 2023-06-21 | 2024-12-26 | Solventum Intellectual Properties Company | Dental article with application device, lubricant composition and dental material |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2168686A (en) * | 1934-11-20 | 1939-08-08 | Multiple Corp | Hypodermic syringe and cartridge |
JPS5988157A (en) * | 1982-11-12 | 1984-05-22 | ジヨ−ジ・コザム | Multi-barrel syringe |
DE3763941D1 (en) | 1986-09-14 | 1990-08-30 | Wilhelm A Keller | DOUBLE DISCHARGE CARTRIDGE FOR TWO-COMPONENT DIMENSIONS. |
DE3873628D1 (en) * | 1987-06-10 | 1992-09-17 | Wilhelm A Keller | DOUBLE DISCHARGE CARTRIDGE FOR TWO-COMPONENT DIMENSIONS. |
US5240146A (en) * | 1990-12-14 | 1993-08-31 | Smedley William H | Variable proportion dispenser |
IT225480Y1 (en) * | 1991-07-05 | 1996-11-18 | Zhermack S R L | MODULAR EQUIPMENT ESPECIALLY FOR THE DOSAGE OF MULTI-COMPONENT F LUID AND / OR PASTOUS PRODUCTS |
US5582596A (en) * | 1992-09-26 | 1996-12-10 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Applicator for applying a biocompatible adhesive |
WO1995022941A1 (en) * | 1994-02-28 | 1995-08-31 | Minnesota Mining And Manufacturing Company | Dual chamber cartridge dispensing system for dental material |
US5918772A (en) * | 1995-03-13 | 1999-07-06 | Wilhelm A. Keller | Bayonet fastening device for the attachment of an accessory to a multiple component cartridge or dispensing device |
DE29720316U1 (en) * | 1997-11-17 | 1998-01-29 | Raimund Andris Gmbh & Co Kg, 78052 Villingen-Schwenningen | Two-chamber dispenser |
JP2000083967A (en) * | 1998-09-14 | 2000-03-28 | Shiyoufuu:Kk | Container for dental composition |
EP1602415A1 (en) | 2004-06-04 | 2005-12-07 | 3M Espe AG | Syringe for a multi-component paste |
ATE462459T1 (en) * | 2004-07-16 | 2010-04-15 | Dentaco Gmbh | MULTI-CHAMBER AMPOULE FOR DISPENSING A MIXTURE CONSISTING OF SEVERAL SUBSTANCES |
US8419722B2 (en) * | 2004-10-29 | 2013-04-16 | Spinal Restoration, Inc. | Apparatus and method for injection of fibrin sealant in spinal applications |
EP1746045B1 (en) * | 2005-07-22 | 2009-09-16 | Dentaco Dentalindustrie- und Marketing GmbH | Multi-chamber dispensing device |
US8376989B2 (en) * | 2009-03-30 | 2013-02-19 | Covidien Lp | Compartmented syringe |
JP5824223B2 (en) * | 2011-03-24 | 2015-11-25 | テルモ株式会社 | Double prefilled syringe |
RU2586308C2 (en) * | 2011-07-28 | 2016-06-10 | Зм Инновейтив Пропертиз Компани | Cartridge for dispensing a dental substance and method of assembling the cartridge |
JP5973365B2 (en) * | 2013-03-01 | 2016-08-23 | 株式会社ジーシー | Dental mixer |
-
2019
- 2019-11-22 JP JP2021531676A patent/JP2022510668A/en active Pending
- 2019-11-22 US US17/309,290 patent/US20220023538A1/en active Pending
- 2019-11-22 WO PCT/IB2019/060072 patent/WO2020115600A1/en unknown
- 2019-11-22 CN CN201980078704.1A patent/CN113164236A/en active Pending
- 2019-11-22 EP EP19813148.4A patent/EP3890652B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2022510668A (en) | 2022-01-27 |
US20220023538A1 (en) | 2022-01-27 |
WO2020115600A1 (en) | 2020-06-11 |
CN113164236A (en) | 2021-07-23 |
EP3890652A1 (en) | 2021-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11642193B2 (en) | Cartridge, a piston and a syringe comprising the cartridge and the piston | |
EP3890652B1 (en) | A syringe for storing and dispensing a material | |
US20110021982A1 (en) | Dispensing device with bypass | |
US8453887B2 (en) | One-piece vented piston | |
US8328553B2 (en) | Device for dispensing material | |
JP4078309B2 (en) | Device for storing, mixing, and dispensing flowable materials | |
US20170265969A1 (en) | Dispensing device for a dental material and a method of filling the device | |
JP5140668B2 (en) | Injector with piston | |
EP2827976B1 (en) | A device for mixing and dispensing flowable components | |
RU176519U1 (en) | Piston | |
US20200139319A1 (en) | A mixer for dispensing a multi-component material | |
EP2621395B1 (en) | Mixing tip for dental materials | |
KR200275653Y1 (en) | Bottle for charging medicine using for injection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210519 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20220705 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602019023755 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1539977 Country of ref document: AT Kind code of ref document: T Effective date: 20230115 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230328 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20221228 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1539977 Country of ref document: AT Kind code of ref document: T Effective date: 20221228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230329 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230428 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230428 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602019023755 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20230929 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602019023755 Country of ref document: DE Owner name: SOLVENTUM INTELLECTUAL PROPERTIES CO. (N.D.GES, US Free format text: FORMER OWNER: 3M INNOVATIVE PROPERTIES COMPANY, SAINT PAUL, MN, US |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231122 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20231122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231122 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20231130 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231122 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231122 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231122 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221228 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20241022 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20241201 Year of fee payment: 6 |